Ordentlich Peter
SEC CIK 1594274 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | CSO | 17.4K | — | $1.92M | 11 | 2022-01-31 | 2023-02-15 |
Most active insiders at SNDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Metzger Michael A | CEO, Dir | — | $1.43M |
| 2 | Botwood Nicholas A.J. | CMO, Head of R, D | — | $1.18M |
| 3 | Goldan Keith A. | CFO | — | $137.0K |
| 4 | Rizo Aleksandra | Dir | — | — |
| 5 | Jarrett Jennifer | Dir | — | — |
| 6 | Huber Martin H. Jr. | Dir | — | — |
| 7 | Legault Pierre | Dir | — | — |
| 8 | Katkin Keith | Dir | — | — |
| 9 | Podlesak Dennis | Dir | — | — |
Ordentlich Peter made no open-market trades at SNDX in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-17 | 2023-02-15 | SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | CSO | M - OptEx | $6.95 | +25.0K | 17.4K | New | +$173.8K |
| DM | 2023-02-17 | 2023-02-15 | SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | CSO | S - Sale+OE | $25.84 | -25.0K | 0 | -100% | -$646.0K |
| D | 2023-02-03 | 2023-02-01 | SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | CSO | S - Sale | $28.43 | -69 | 0 | -100% | -$1,962 |
| D | 2023-02-03 | 2023-01-31 | SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | CSO | J - Other | $17.32 | +69 | 69 | New | +$1,195 |
| DM | 2022-12-02 | 2022-12-01+ | SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | CSO | M - OptEx | $6.38 | +25.0K | 4,037 | New | +$159.4K |
| DM | 2022-12-02 | 2022-12-01+ | SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | CSO | S - Sale+OE | $25.04 | -25.0K | 265 | -99% | -$625.9K |
| D | 2022-08-26 | 2022-07-29 | SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | CSO | J - Other | $14.12 | +265 | 265 | New | +$3,742 |
| DM | 2022-08-26 | 2022-08-24 | SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | CSO | M - OptEx | $6.32 | +25.0K | 23.1K | New | +$158.1K |
| DM | 2022-08-26 | 2022-08-24 | SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | CSO | S - Sale+OE | $25.04 | -25.0K | 265 | -99% | -$626.0K |
| D | 2022-02-03 | 2022-02-01 | SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | CSO | S - Sale | $16.65 | -1,412 | 0 | -100% | -$23.5K |
| D | 2022-02-03 | 2022-01-31 | SNDX | Syndax Pharmaceuticals Inc | Ordentlich Peter | CSO | J - Other | $12.39 | +1,412 | 1,412 | New | +$17.5K |
Purchase Sale Sale after option exercise All abbreviations